(2022) Nanosponges: An overlooked promising strategy to combat SARS-CoV-2. Drug Discov Today. ISSN 1359-6446 (Print) 1359-6446
Full text not available from this repository.
Abstract
Among explored nanomaterials, nanosponge-based systems have exhibited inhibitory effects for the biological neutralization of, and antiviral delivery against, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). More studies could pave the path for clarification of their biological neutralization mechanisms as well as the assessment of their long-term biocompatibility and biosafety issues before clinical translational studies. In this review, we discuss recent advances pertaining to antiviral delivery and inhibitory effects of nanosponges against SARS-CoV-2, focusing on important challenges and opportunities. Finally, as promising approaches for recapitulating the complex structure of different organs/tissues of the body, we discuss the use of 3D in vitro models to investigate the mechanism of SARS-CoV-2 infection and to find therapeutic targets to better manage and eradicate coronavirus 2019 (COVID-19).
Item Type: | Article |
---|---|
Keywords: | Antiviral delivery Biological neutralization Covid-19 Nanosponges SARS-CoV-2 Viral inactivation |
Journal or Publication Title: | Drug Discov Today |
Journal Index: | Pubmed |
Identification Number: | https://doi.org/10.1016/j.drudis.2022.07.015 |
ISSN: | 1359-6446 (Print) 1359-6446 |
Depositing User: | Zahra Otroj |
URI: | http://eprints.mui.ac.ir/id/eprint/16649 |
Actions (login required)
View Item |